Stay updated on Amivantamab in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab in Gastric Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.1%
    Check dated 2025-05-08T09:58:45.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-05-01T05:10:54.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-04-23T22:11:43.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding a Phase 2 study of amivantamab for gastric and esophageal cancer, including detailed inclusion and exclusion criteria. Additionally, a new identifier and revision number have been added.
    Difference
    14%
    Check dated 2025-04-16T14:35:26.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T09:28:20.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-01T23:28:47.000Z thumbnail image

Stay in the know with updates to Amivantamab in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.